Antibody responses after intravaginal immunisation with trimeric HIV-1(CN54) clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation

Optimum strategies to elicit and maintain antibodies at mucosal portals of virus entry are critical for the development of vaccines against human immunodeficiency virus (HIV). Here we show in non-human primates that a novel regimen of repeated intravaginal delivery of a non-adjuvanted, soluble recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cranage, Martin P., Fraser, Carol A., Cope, Alethea, McKay, Paul F., Seaman, Michael S., Cole, Tom, Mahmoud, A. Nasir, Hall, Joanna, Giles, Elaine, Voss, Gerald, Page, Mark, Almond, Neil, Shattock, Robin J.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Science 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060343/
https://www.ncbi.nlm.nih.gov/pubmed/21187177
http://dx.doi.org/10.1016/j.vaccine.2010.12.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060343/
https://www.ncbi.nlm.nih.gov/pubmed/21187177
http://dx.doi.org/10.1016/j.vaccine.2010.12.034

Ejemplares similares